Moderna, Inc. is a company in the U.S. stock market and it is a holding in 120 U.S.-traded ETFs. MRNA has around 22.7M shares in the U.S. ETF market. The largest ETF holder of MRNA is the Invesco QQQ Trust (QQQ), with approximately 4.87M shares. Investors may also find of interest that the ETF with the largest allocation to MRNA stock is ETFMG Treatments Testing and Advancements ETF (GERM), with a portfolio weight of 4.20%. On average, U.S. ETFs allocate 0.66% of MRNA to their portfolios.
Additionally, MRNA is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with MRNA as a holding is the Direxion Daily S&P Biotech Bull 3X Shares (LABU), with a return of 109.92%.